Cargando…
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
Metformin, the most widely prescribed anti-diabetic drug, is shown to possess anti-cancer potential in treatment of cancers, including breast cancer; decreases breast cancer risk; and improves overall survival. However, reports suggest that higher glucose concentrations may negatively impact the ant...
Autores principales: | Varghese, Sharon, Samuel, Samson Mathews, Varghese, Elizabeth, Kubatka, Peter, Büsselberg, Dietrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359242/ https://www.ncbi.nlm.nih.gov/pubmed/30626087 http://dx.doi.org/10.3390/biom9010016 |
Ejemplares similares
-
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
por: Samuel, Samson Mathews, et al.
Publicado: (2019) -
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
por: Varghese, Elizabeth, et al.
Publicado: (2021) -
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020) -
Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
por: Varghese, Elizabeth, et al.
Publicado: (2018) -
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
por: Samuel, Samson Mathews, et al.
Publicado: (2021)